Nephrology Doctors in Great Neck, NY Accepting Medicare

9 Nephrology doctors found. Showing 1 - 9

Madhu Bhaskaran, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: Nephrology, 100 Community Drive, Great Neck, NY 11021 Phone: 516-465-8210

Akhtar Ashfaq, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 100 Community Dr, Great Neck, NY 11021 Phone: 516-465-8200    Fax: 516-465-8202

Dr. Azzour Hazzan, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 100 Community Dr, Great Neck, NY 11021 Phone: 516-465-8200    Fax: 516-465-8202

Dr. Kenar Dinesh Jhaveri, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 100 Community Dr Fl 2, Division Of Nephrology, North Shore Univ Hospital, Great Neck, NY 11021 Phone: 516-465-8200

Michael D Gitman, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 100 Community Dr, Great Neck, NY 11021 Phone: 516-465-8200    Fax: 516-465-8202

Ilene Miller, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: Nsuh Dept Of Medicine Nephrology, 100 Community Drive, Great Neck, NY 11021 Phone: 516-465-8200

Dr. Susana Hong, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 100 Community Dr Fl 2, Great Neck, NY 11021 Phone: 516-465-8200    Fax: 516-465-8202

Alessandro Bellucci, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: Nsuh Dept Of Medicine Nephrology, 100 Community Drive, Great Neck, NY 11021 Phone: 516-465-8200

Toni-marie Pernick, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 891 Northern Blvd, Great Neck, NY 11021 Phone: 516-775-7555

News Archive

BIND announces data from BIND-014 Phase 1 trials on prostate cancer

Nanomedicine research at the David H. Koch Institute for Integrative Cancer Research at MIT funded by a $5 million grant from the Prostate Cancer Foundation (PCF) has delivered the first nanomedicine shown to successfully target prostate cancer cells and deliver docetaxel chemotherapy in high concentrations in Phase I clinical trials.

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.

Bolder BioTechnology awarded NIH grant to continue development of growth hormone product

Bolder BioTechnology, Inc. today announced that it has been awarded a $1.9 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH).

Cardiac sympathetic denervation the heart's control from the sympathetic nervous system

Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.

Read more Medical News

› Verified 6 days ago